Temporal trends and factors associated with survival after Pneumocystis carinii pneumonia in California, 1983-1992

American Journal of Epidemiology

Volumn 146, Issue 2, 1997, Pages 115-127

  Colford Jr , John M ^a,b,c   Segal, Mark ^b   Tabnak, Farzaneh ^c   Chen, Mi ^c,d   Sun, Richard ^c   Tager, Ira ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acquired immunodeficiency syndrome; AIDS related opportunistic infections; Models, statistical; Mortality; Pneumocystis carinii; Pneumonia, Pneumocystis carinii; Proportional hazards models; Regression analysis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL;

EID: 0030855131     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009242     Document Type: Article

References (24)

1. Jacobson LP, Kirby AJ, Polk S, et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol 1993;138:952-64.
2. Castellano AR, Nettleman MD. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. JAMA 1991;266:820-4.
3. Harris JE. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA 1990;263:397-401.
4. Lundgren JD, Barton SE, Katlama C, et al. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome: Multicentre Study Group on AIDS in Europe Arch Intern Med 1995;155:822-8.
5. Bastian L, Bennett CL, Adams J, et al. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr 1993;6:617-23.
6. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
7. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika 1990;77:147-60.
8. SAS Institute. Statistical analysis system (SAS). Cary, NC: SAS Institute, 1988.
9. STATA Corporation. Stata statistical software: release 4.0. College Station, TX: Stata Corporation, 1995.
10. Statistical Sciences Inc. S-PLUS guide to statistical and mathematical analysis, version 3.3. Seattle, WA: Mathsoft, Inc., 1995.
11. Breiman L, Friedman JH, Olshen RA, et al. Classification and regression trees. London: Chapman and Hall, 1984.
12. Gordon L, Olshen RA. Tree-structured survival analysis. Cancer Treat Rep 1985;69:1065-9.
13. Piette JD, Intrator O, Zierler S, et al. An exploratory analysis of survival with AIDS using a nonparametric tree-structured approach. Epidemiology 1992;3:310-18.
14. Segal M. Regression trees for censored data. Biometrics 1988; 44:35-47.
15. Segal MR. Extending the elements of tree-structured regression. Stat Methods Med Res 1995;4:219-36.
16. LeBlanc M, Crowley J. Relative risk trees for censored survival data. Biometrics 1992;48:411-25.
17. Blum S, Singh TP, Gibbons J, et al. Trends in survival among persons with acquired immunodeficiency syndrome in New York City the experience of the first decade of the epidemic. Am J Epidemiol 1994;139:351-61.
18. Enger C, Graham N, Peng Y, et al. Survival from early, intermediate, and late stages of HIV infection. JAMA 1996; 275:1329-34.
19. Phillips AN, Sabin CA, Elford J, et al. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts. Am J Epidemiol 1993;138:870-8.
20. Masur H. Prevention and treatment of pneumocystis pneumonia. N Engl J Med 1992;327:1853-60. (Erratum: N Engl J Med 1993;328:1136).
21. Martin JN, Colford JM Jr, Ngo L, et al. Effect of older age on survival in human immunodeficiency virus (HIV) disease. Am J Epidemiol 1995;142:1221-30.
22. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995;333:751-6.
23. Kitahata MM, Koepsell TD, Deyo RA, et al. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996;334:701-6.
24. Collier A, Coombs R, Schoenfeld D, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med 1996;334:1011-17.